CEO Attaché

• You have a have a scientific background - ideally a Master's or PhD in life sciences, biotech, chemistry, or a related field - and you can engage credibly with researchers and pharma partners on the substance of what they do

• Familiarity with biotech IP licensing, research collaboration agreements, or venture deal structures

• Experience working across US and European markets and navigating international stakeholder relationships

• Interest in or exposure to decentralised science, Web3, or token-based funding models

• Experience building or managing a CRM or deal-tracking system from scratch

Molecule and BIO.xyz are building the foundation of Decentralized Science (DeSci) - where biotech meets web3 to make scientific research community-owned, transparent, and faster to market.

Molecule provides the infrastructure to turn intellectual property (IP) into programmable, on-chain assets through our IP-NFT framework and evolving protocol stack. This enables researchers, patients, and communities to fund and govern biotech projects in new, open ways.

BIO.xyz is the coordination and economic layer of DeSci, powering BioDAOs through funding, governance, and ecosystem alignment.

Together, we are creating a new model for scientific discovery - one where breakthroughs are owned and advanced by the communities that believe in them.

We're looking for a sharp, commercially-minded operator to work directly alongside Molecule's CEO. This role sits at the centre of everything - driving BD pipeline, managing investor relationships, handling high-priority communications with enterprise pharma partners, and ensuring nothing falls through the cracks in a fast-moving organisation.

Molecule's Commercial Team runs a high volume of concurrent partnerships across pharma, biotech, academic institutions, and investors. Deals get introduced, calls happen, and then things need someone relentless to keep them moving. You'll work closely with the CEO and our Commercial Team to manage the pipeline, maintain investor relations across 70+ existing investors, and build the systems that make all of this scalable.

This is a role for someone who can context-switch between a pharma licensing conversation and an investor update without missing a beat - and who understands why what Molecule is building matters for the future of drug development.

• Own follow-through on BD pipeline - track active deal workstreams across enterprise, academic, and biotech partnerships, ensure nothing stalls, and surface the right opportunities to leadership at the right time

• Manage and build investor relations - maintain relationships with 70+ existing investors through regular updates, slide decks, and follow-ups, and drive new investor relationships forward alongside the CEO and the Commercial Team.

• Triage enterprise, pharma, and investor correspondence with sound commercial judgement

• Coordinate and prepare for high-stakes calls and meetings across time zones, ensuring the Team walks into every conversation fully briefed

• Draft and refine investor communications, partnership proposals, and internal updates on behalf of the Commercial Team

• Build and maintain a commercial system - create structure around how BD opportunities are categorised, tracked, and reported internally (think: our own lean CRM)

• Coordinate cross-functional deal activity - many of Molecule's BD engagements span organisations and teams; you'll be the connective tissue that keeps everyone aligned

• Analyse the science behind partnerships - evaluate incoming opportunities with enough scientific literacy to triage what's worth pursuing and brief leadership accordingly

• Jump on calls with partners and investors as a credible representative of Molecule when needed

Full-time | Globally flexible, but US preferred - Travel required | Start: Immediately

• You have previously worked in a VC fund

• You're commercially hungry. Whether you came from tech sales at a startup, BD at a health-tech company, or you taught yourself commercial skills alongside your academic work - you understand pipeline, follow-up, and what it takes to close

• You're not typically corporate. We're not looking for someone who climbed the ladder at a large pharma company. We want someone scrappy - think a biotech startup, or someone who hustled their way through a top programme and is now looking for real ownership

• You're organised and relentless about follow-through. The biggest gap this role fills is making sure that the volume of relationships and deals Molecule generates don't fall through the cracks

• You're a strong communicator - equally comfortable drafting a board-level investor memo and hopping on a call with a lab partner or KOL

• You thrive in complexity and are energised by managing multiple priorities across deals, relationships, and internal coordination simultaneously

• You have global flexibility - ideally willing to spend the first several months in Berlin for onboarding and relationship-building with the core team

• Exposure to enterprise pharma, institutional investors, and cutting-edge research partnerships globally

• A team that values substance over titles, speed over process, and people who've built their way up

• Competitive compensation including token-based upside

We are an equal opportunity employer. We are committed to equality and weaving a community that values diverse perspectives and experiences and are actively seeking a diverse pool of applicants. All employment decisions are made without regard to race, colour, national origin, ancestry, sex, gender, gender identity or expression, sexual orientation, age, genetic information, religion, disability, medical condition, pregnancy, marital status, family status, veteran status, or any other characteristic protected by law.